Moreover, a novel DGKα specific inhibitor CU-3, which was successfully obtained after a high-throughput screening of about 9600 chemical compounds, induced apoptosis in HepG2 HCC cells and HeLa cervical cancer cells, while simultaneously enhancing immune response by promoting IL-2 production [101]. This evidence concerns the gene DGKA and hepatocellular carcinoma.